News + Filings Holdings
|
Aisling Capital Management LP
|
|
Changes: All | New | Increased | Decreased | Sold Out |
Portfolio as of: |
Name | Ticker | Class | Shares | Change | Value | Change | % Port | % OS | Hist | Date |
BridgeBio Pharma, Inc.
| BBIO | Common | 6,068,125 | 0 | 104,371,750,000 | 3,762,237,000 | 51.13 | 3.78 |
Hist
| 06/30/2023 |
Verona Pharma plc
| VRNA | SPONSORED ADS | 1,115,352 | 0 | 23,578,541,000 | 1,182,273,000 | 11.55 | |
Hist
| 06/30/2023 |
Syndax Pharmaceuticals Inc
| SNDX | Common | 1,025,000 | 0 | 21,453,250,000 | -194,750,000 | 10.51 | 1.49 |
Hist
| 06/30/2023 |
Biomea Fusion, Inc.
| BMEA | Common | 798,757 | 0 | 17,532,716,000 | -7,236,739,000 | 8.59 | |
Hist
| 06/30/2023 |
Monte Rosa Therapeutics, Inc.
| GLUE | Common | 1,472,331 | 0 | 10,085,467,000 | -1,383,991,000 | 4.94 | 2.98 |
Hist
| 06/30/2023 |
Reneo Pharmaceuticals, Inc.
| RPHM | Common | 886,075 | 0 | 5,812,652,000 | 513,923,000 | 2.85 | 2.63 |
Hist
| 06/30/2023 |
Nuvation Bio Inc.
| NUVB | Common | 2,541,009 | 0 | 4,573,816,000 | 355,741,000 | 2.24 | |
Hist
| 06/30/2023 |
Aclaris Therapeutics, Inc.
| ACRS | COM | 434,455 | 0 | 4,505,298,000 | 990,557,000 | 2.21 | 0.61 |
Hist
| 06/30/2023 |
Elevation Oncology, Inc.
| ELEV | COM | 2,834,910 | 0 | 4,309,063,000 | -1,077,266,000 | 2.11 | 11.65 |
Hist
| 06/30/2023 |
SPRUCE BIOSCIENCES, INC.
| SPRB | Common | 1,205,511 | 0 | 2,591,849,000 | -72,330,000 | 1.27 | 3.03 |
Hist
| 06/30/2023 |
Poseida Therapeutics, Inc.
| PSTX | Common | 1,043,267 | 0 | 1,836,150,000 | -1,377,112,000 | 0.90 | 1.20 |
Hist
| 06/30/2023 |
Marker Therapeutics, Inc.
| MRKR | COMMON | 314,286 | 314,286 | 974,286,000 | 974,286,000 | 0.48 | 3.57 |
Hist
| 06/30/2023 |
AVROBIO, Inc.
| AVRO | Common | 1,009,779 | 0 | 959,391,000 | -50,388,000 | 0.47 | 2.29 |
Hist
| 06/30/2023 |
Aeglea BioTherapeutics, Inc.
| AGLE | COM | 1,691,151 | 0 | 761,864,000 | 271,430,000 | 0.37 | 2.59 |
Hist
| 06/30/2023 |
Viracta Subsidiary, Inc.
| VIRX | Common | 288,571 | 0 | 406,885,000 | -51,943,000 | 0.20 | |
Hist
| 06/30/2023 |
Atreca, Inc.
| BCEL | Common | 387,653 | 0 | 379,900,000 | -62,024,000 | 0.19 | |
Hist
| 06/30/2023 |
Marker Therapeutics, Inc.
| MRKR | Common | 0 | -314,286 | 0 | -223,143,000 | 0.00 | 0.00 |
Hist
| 06/30/2023 |
|
|
|
|